Debbi H. Conlon

Tumor infiltrating Foxp3⁺ regulatory T‐cells are associated with recurrence in pathologic stage I NSCLC patients

Rebecca P. Petersen, Michael J. Campa, Justin Sperlazza et al. · Cancer · 2006 · 432 citations · Full text

High Gene Expression of <i>TS1</i>, <i>GSTP1</i>, and <i>ERCC1</i> Are Risk Factors for Survival in Patients Treated with Trimodality Therapy for Esophageal Cancer

Mary‐Beth Joshi, Yoshinori Shirota, Kathleen D. Danenberg et al. · Clinical Cancer Research · 2005 · 138 citations · Full text

Predicting the sites of metastases from lung cancer using molecular biologic markers

Thomas A. D’Amico, Thomas A. Aloia, Mary-Beth H Moore et al. · The Annals of Thoracic Surgery · 2001 · 82 citations

Tumor Heterogeneity, Medicine, Biomarker Target +10

Neighborhood‐level socioeconomic determinants impact outcomes in nonsmall cell lung cancer patients in the Southeastern United States

Loretta Erhunmwunsee, Mary‐Beth Joshi, Debbi H. Conlon et al. · Cancer · 2012 · 70 citations · Full text

Measurement of chemoresistance markers in patients with stage iii non–small cell lung cancer: a novel approach for patient selection

Kelli Brooks, Kathleen To, Mary‐Beth Joshi et al. · The Annals of Thoracic Surgery · 2003 · 51 citations

Prognostic Biomarkers, Chemoresistance Markers, Cancer Detection +9